Company intelligence / Profile preview

C2 Pharma

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

C2 Pharma is a global leader in manufacturing and distributing high-quality ophthalmic and niche active pharmaceutical ingredients. The company supplies more than 200 pharmaceutical companies worldwide with a portfolio of complex chemical compounds derived from both synthetic and natural sources. It emphasizes sustainability through programs supporting ethical sourcing of raw materials such as pilocarpine. No clinical trial results are reported since the company does not develop finished drugs.

Therapeutic areas: CardiovascularOphthalmology
Modalities: Small moleculePeptides
Industry: Contract Manufacturing Organization

Drug pipeline

3 assets

atropine sulfate

Commercial

Indications: Ophthalmology

2 more assets in the full pipeline.

Partnerships

Partnerships for a Better World program for sustainable sourcing of raw materials like pilocarpine

Beyond the preview

Go deeper on C2 Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C2 Pharma.